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In the Southwest, ultraviolet carcinogenesis is
a major problem. Unna (1) called attention to
the fact that skin cancers were quite common in
sailors and individuals exposed to sunlight over
prolonged periods of time. Farmers, ranchers,
and other outdoor workers in our area receive
large amounts of ultraviolet irradiation, and skin
cancer of both the squamous and basal cell types
is quite common in these individuals. The differ-
ences in skin cancer in an area of intense sun-
light, El Paso, and an area having considerably
less sunshine, Connecticut, have been statisti-
cally studied by MacDonald (2). The incidence of
skin cancer was significantly greater in El Paso
and the lesions were found to be distributed over
the areas exposed to sunlight in numbers some-
what proportionate to the amount of sunlight
reaching these areas. Reviewing the evidence on
this subject, Blum (3) concluded that sunlight
is a major cause of cancer of the skin in man.
Topical sunscreens have been used to prevent
sunburn in swimmers, sun bathers, fishermen,
etc., but have not been generally recommended
for protecting individuals from ultraviolet car-
cinogeaesis. This may be due, in part, to a lack
of reports in the literature indicating that sun-
screens would be effective for this purpose. In
discussing a paper by Griffin et at. (4), Rothman
mentioned that he has been able to inhibit ultra-
violet carcinogenesis in experimental animals
by the topical application of para-aminobenzoic
acid. It would appear to be worthwhile to estab-
lish a practical way of decreasing the incidence of
ultraviolet induced skin cancer in man.
Various members of the bcnzophcnone family
have been shown to be excellent sun-screening
agents (5); therefore, a representative bcnzo-
phenone, 3-benzoyl-4-hydroxy-6-methoxy-ben-
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zenesulfonic acid, was chosen for evaluation as
to its ability to prevent the development of
untraviolct-induced skin cancers in albino mice.
In selected experiments, 3-benzoyl-4-hydroxy-6-
mcthoxy-bcnzenesulfonic acid (BSA) was com-
pared with para-aminobenzoic acid (PABA).
MATERIALS AND METHODS
In a series of experiments, Swiss strain albino
mice were irradiated in their wire mesh cages after
BSA, a control vehicle or PABA had been applied
to their ears. At the beginning of each experiment,
the animals were 8 to 10 weeks old. Some animals
were irradiated with a high intensity mercury arc
lampt and others with the longer rays of a Wood's
type lamp.t When the latter type irradiation was
employed, S-methoxypsoralen (8-MP) was admin-
istered to activate the usually harmless lnnger
wave lengths emitted by this light source. Factors,
such as room temperature and extraneous room
light, were identical for treated animals and
controls. Water and food were taken ad libitum.
Experiment I
In this experiment, BSA was applied topically
to determine if the incidence of ultraviolet light-
induced carcinogenesis could be reduced. Ten
per cent BSA in alcohol was applied to each
animal's right car, and the alcoholic vehicle was
applied to the left ear. The animals were then
irradiated for 15 minutes daily over a 5 months
period at a distance of 50 cm. from the mercury
arc lamp. The total energy received was 77 x
l0' ergs/cm.2. During the period of treatment and
post treatment observation there was no visible
damage in the ears protected with BSA; whereas,
48% of the control animals' ears were damaged.
The final tumor incidence was only 3% in ears
protected with BSA; whereas, 27% of the control
ears developed tumors. Sec Table 1.
Experiment 2
In this experiment, the erythematous response
alone was studied, and BSA was compared with
t G. E. Uviarc lamp (UA-3).
Blak-Ray, Model XX-15, long wave ultra-
violet (3200—4000 A with maximum transmission
at 3660 A). Ultra-Violet Products, Inc., San Ga-
briel, Calif.
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TABLE 1
The Effect of Topical Application of BSA with Subsequent Ultraviolet Exposure
15 mm/day for 5 months at 50 cm. from
mercury arc lamp.
Energy Received
77 X 10 ergs/cm.2
No. of
Animals
(Started!
survived)
Treatment Percentage of ErythematousDamage in Ears
Therapeutic
Administration Ultraviolet Irradiation
No Da-
mage Slight
Vry
Damage
Slight Mod.
Damage Damage
Severe
Damage
20/15 Controls
—
20 min./day for 5 months at 50 cm. from
mercury arc lamp
Energy Received
1 X 1010 ergs/cm.2
— 3% 27% 57% 13%
———
29%
—
21%Right ears
5% BSA
Left ears
5% PABA
——-—
—
—
—
——
—
25% 17% 8% —
PABA. Twenty animals served as controls, and
20 animals had the right ears painted with a
5% concentration of BSA in alcohol, while the
left ears were painted with a 5% solution of
PABA in alcohol. The animals were irradiated
for 20 minutes daily over a 5 month period with
the mercury arc lamp at a distance of 50 cm.
Energy received was 1 )< 1010 ergs/cm.2. Results
are presented in Table 2. Both BSA and PABA
provided considerable protection under the
conditions of this experiment. BSA appeared to
be slightly superior to PABA.
Experiment 3
The effect of topical applications of BSA on
mice treated with 8-MP was studied. Three
groups of animals were employed, and in each
group the right ear was painted with BSA and
the left ear with the vehicle alone. One group
served as controls, another received 8-MP in the
diet, and the third group received 8-MP by
injection. The animals were then irradiated with
the mercury arc lamp for 20 minutes daily over
a 5 month period. They received 50 >< 108 ergs/
cm.2, of energy. These results, presented in Table
3, show that BSA provided excellent protection
even when the erythematous and carcinogenic
response was accelerated by the injection of
8-MP.
Experiment 4
This experiment was similar to Experiment 3
except that the length of the daily exposures
was decreased and the experiment was extended
from 5 months to 8 months duration. The results
were essentially the same as those in Experi-
ment 3; however, the intraperitoneal injection
of 8-MP accelerated responses to the point that
BSA permitted some damage and a final tumor
incidence of 25%. The unprotected animals
Swiss Albino
Mice
Treatment Results
Topical Application Ultraviolet Irradiation Percentage EarsGrossly Damaged
Percentage
Ear Tumors
Right ears 10% BSA in
alcohol
Left ears Alcohol
No visible
damage
3%
48%
* Many of the left ears were totally sloughed off, thus reducing the possibility of a larger tumor
incidence.
TABLE 2
The Effect of BS.4 on the Erythematous Response Following Prolonged Ultraviolet Irradiation
27%*
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TABLE 5
Effect of BSA after 8-MP Injection and Exposure to Longer Ultraviolet Wave Lengths
No. of
Animals Treatment
Degree of Damage in Mire Percentage of Tumors
(Started/
Survived) tar0.4 mg. 5-MP Longer wave length ultravioletirradiation (3200-4000 A)
20/14
— —
20/19
Controls
——-——-—
Left ears:
Alcohol
Right ears:
10% BSA
5 mm/day for 4 wke.; then 10 mio./
day for 14 wko.; then 4 mm/day
for 2 wke. at 45 em. from Elak-Ray
lamp.
Energy Received:
11 X 10° erge/cm.i
All ears severely damaged.
Moot eyes damaged—many
with cataracts.
Questionable tumors (21%)
Definite tumors (29%)
—__________________
Left ears:
Slight damage (22%)
Moderate damage (33%)
Severe damage (44%)
Right cars:
Normal (89%)
Slight damage (12%)
Left ears:
Questionable tumors (12%)
Right ears:
Tumors (0%)
TABLE 6
Repeat of Experiment 5 with Decreased Amount of Daily Irradiation
No. of
Animals Treatment
PerceotageofE'trernatous Percentage of Tumors in Ears
(Started/
Survived)
All mice injected
with 0.4 mg. s-MP
Longer wave length ultravio-
let irradiation (3200—4000 A)
20/14
20/13
Controls
Left ears:
Alcohol
Right ears:
10% BSA
5 min./day for 5
months at 45 em.
from Blak-Ray
lamp
Energy Received:
3.6 X 10° ergs/cm.°
No damage (14%)
Slight damage (14%)
Moderate damage (14%)
Severe damage (57%)
Questionable tumors (15%)
Definite tumors (43%)
Left ears: Left ears:
Slight damage (15%) Questionable tumors
Moderate damage (23%) (31%)
Severe damage (62%) Definite tumors (23%)
Right ears: Right ears:
No damage (77%) Questionable tumor (15%)
Slight damage (23%) Definite tumors (0%)
Experiment 8
Experiment S was similar to experiment 7
except that the longer wave lengths produced
by the Blak-Ray lamp were employed. The
animals were irradiated at a distance of 45 em.
and the energy received was 1.4 x 10° ergs/em.°.
Under the conditions of this experiment BSA
was superior to PABA. This was to be expected
since BSA has a wider absorption spectrum.
COMMENT
The above experiments show that experi-
mental ultraviolet eareinogenesis can be reduced
by the topical application of BSA or PABA.
animals were irradiated for 5 minutes daily over
a 5 month period at a distance of 45 cm. The
energy received was 3.6 x 10° ergs/cm.2.
Experiment 7
BSA and PABA were compared in this study.
Some of the animals were fed S-MP in their diet
and others ate a normal diet. All were irradiated
with the mercury are lamp over a six month
period. The distance was 50 em. and the energy
received was 10.2 x 10° ergs/cm.a. Both agents
were very effective in preventing erythema and
damage. PABA was slightly superior when S-MP
was administered.
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TABLE 7
Effect of Topical Application of BSA and PABA in Mice Treated with 8-MP Prior to
Irradiation with Mercury Arc Lamp
No.
ifMice
Treatment Degree of Damage
Diet Ultraviolet Irradiation Right Ears—BSA Left Ears—PABA
13
——
16
12
Normal
diet
—————
8-MP in
diet
8-MP in
diet
15 mm/day for 6 months at 50
cm. from mercury arc lamp.
Energy Received:
10.2 X 10 ergs/cm.2
No damage (68%)
Slight damage (23%)
Moderate damage (9%)
———- —
No damage (50%)
Slight damage (25%)
Moderate damage (19%)
Severe damage (6%)
No damage (61%)
Slight damage (30%)
Severe damage (9%)
No damage (75%)
Slight damage (19%)
Moderate damage (6%)
Control animals—Nothing applied to ears
Severe damage (100%)
TABLE 8
Effect of Topical Application of BSA and PABA in Mice Treated with 8-MP Prior to
Irradiation with Longer Ultraviolet Wave Lengths
No
?fMice
Treatment
—-
Degree of Damage
Diet Ultraviolet Irradiation Right Ears—BSA Left Ears—PABA
16
—
13
15
Usual diet
-——-
8-MP in
diet
8-MP in
diet
15 min./day for 6 months at 45
em. from Blak-Ray lamp.
(3200—4000 A)
Energy Received:
1.4 X 10 ergs/cm.2
No damage (100%)
—--———
No damage (92%)
Slight damage (8%)
No damage (100%)
No damage (68%)
Slight damage (23%)
Moderate damage (9%)
Control animals—Nothing applied to ears
No damage (26%)
Slight damage (33%)
Moderate damage (17%)
Severe damage (24%)
These findings in experimental animals may or
may not be applicable to man; however, physi-
cians should probably begin recommending a
good sunscreen for fair—skinned individuals who
are chronically exposed to sunlight. Once the
process of ultraviolet carcinogenesis is initiated,
it proceeds without further exposure. Therefore,
damage that has already been done cannot be
reversed. Nevertheless, in many individuals it is
important to prevent additional damage. The
earlier protective measures are instituted in sus-
ceptible persons, the less prone they should be
toward developing actinically induced skin
cancer. At this point it should be emphasized that
skin cancers are found most frequently in fair-
skinned individuals and that Negroes rarely, if
ever, develop actinically induced skin cancers.
In similar studies, to be presented elsewhere,
the authors have found that the oral adminis-
tration of chloroquine, Triquin*, or BSA will
also markedly decrease the incidence of experi-
mental ultraviolet light carcinogenesis (6).
In these experiments BSA was compared with
PABA on a weight for weight basis in contrast
to a mole for mole study. A mole for mole eval-
uation would increase the weight of BSA in the
* Triquin—chloroquine diphosphate, quina-
crine hydrochloride, and hydroxychloroquine.
Winthrop Laboratories, New York, N. Y.
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formulation and therefore the effectiveness.
Since results with BSA and PABA were quite
similar when the total spectrum high intensity
mercury arc lamp was employed, it would
appear that either agent would provide adequate
protection from sunlight. BSA has a wide absorp-
tion spectrum, is stable, and has a low sensitizing
index (5).
5UMMAEY
1. In a series of experiments utilizing albino
mice, the topical application of 3-benzoyl-4-
hydroxy-6-methoxy-benzenesulfonie acid (BSA)
and para-aminobenzoic acid (PABA) were
found to decrease both the erythematous and
carcinogenic effect of ultraviolet light.
2. To accelerate the response or to activate
usually harmless longer wave lengths, 8-
methoxypsoralen (8-MP) was administered in
selected experiments.
3. It was concluded that effective sunscreens
such as BSA and PABA should be recommended
for individuals prone to develop ultraviolet
induced skin cancer.
The 3-benzol-4-hydroxy-6-methoxy-benzenesul-
fonie acid (Uvinul MS 40) was supplied by the
Antara Chemicals Division, General Aniline &
Film Corp., 435 Hudson Street, New York 14,
N.Y.
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DISCUSSION
DR. ALLAN L. LoruNez (Chicago, Ill.): I think
Dr. Knox should be congratulated for keeping
alive this important subject in skin cancer pro-
phylaxis. Perhaps with a little more propaganda
excessively sun-exposed population groups can
be induced to regularly use effective sun-screening
preparations.
Dr. Knox mentioned that a number of years
ago Dr. Rothman, Miss Lasher and I had done
some very similar experiments which demon-
strated that topically applied p-amino benzoie
acid very effectively prevented ultraviolet-in-
duced cancer in mice. This point is discussed in
the forthcoming book, "The Human Integument
in Health and Disease" which represents the
proceedings of a recent symposium held under
the auspices of the American Association for the
Advancement of Science and which was jointly
sponsored by the Society for Investigative
Dermatology and the Committee on Cosmetics
of the A.M.A.
On occasion it has been claimed that the car-
cinogenic wavelengths of ultraviolet include
some of the very short wavelengths even down
to the 2537 Angstrom wavelength of the mercury-
vapor spectrum. We feel this is very unlikely
on the basis of the effective protection offered by
PABA and its relatively narrow range of ultra-
violet filtration. This range extends between
about 2800 and 3100 Angstroms and just about
exactly coincides with the sunburn spectrum yet
allows passage of the shorter ultraviolet wave-
lengths amply present in the radiation from the
mercury-vapor sources used in the eareinogenetie
experiments.
DR. ERWIN P. ZEI55LER (Winnetka, Ill.):
I don't like to monopolize the discussion. It so
happens that I am very heavily involved in
cancer research. Dr. Knox's paper was an ex-
tremely interesting one. It would be interesting
to know what the ergosterol content of the
epidermis was as the result of the irradiation. A
few months ago when I visited the Air Force
Radiation Laboratory at the University of
Chicago, Dr. John Dowe suggested to me that
we study the organic phenolie lyophilizate that
we had recovered from the liquid exudation of
ordinary varieties of lawn grasses. The purpose
of establishing this laboratory, a part of the
pharmacology department was to discover new
radioproteetive chemicals. Among the 30 chemi-
cals Dr. Dowe was studying were phenones,
urea compounds, some chemicals they syn-
thesized in their own laboratories. Fifteen
minutes after the intraperitoneal injection of
sublethal doses of the chemicals, the mice re-
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ceived 800 r units of x-ray in a single dose given
by rotation as a total body irradiation. The
dosage was equivalent to 2 per cent of the body
weight of the animal and made into an isotonic
solution. The lifespan of the mouse was carefully
tabulated and it was found that six of the chemi-
cals, including the phenones and some nitrites
had radiosensitive properties. On the other
hand, three had the very opposite effect; i.e.
increased significantly the lethality of the x-rays,
which apparently acted synergistically with the
chemical. The most marked increase was found
with the phenolie plant material, or lyophylo-
side I supplied.
DR. STEPHEN ROTHMAN (Chicago, Ill.): I wish
to congratulate Dr. Knox on this fine piece of
work. Many years ago I planned to introduce
en masse sun protection with p-aminobenzoic
acid creams in the State of Texas as a public
health measure. I was told, however, that the
rugged Texas farmer never would be talked into
putting some cream on his face. Still, I believe
this could be done with some clever propaganda
and certainly would be more desirable than
using psoralens, the safety and cancer-preventing
effect of which are rather questionable.
DR. MARION B. SULZBERGER (New York,
N. Y.): I guess the people in New York are not
as rugged as the people in Texas, and are more
anxious to protect themselves from carcinomas
and the sun. In our practices in clinic and office,
we have been using sun screening agents topi-
cally applied now as long as I can remember;
and when they are put in pleasant form of lotions
and creams the people in New York City and
vicinity use them, I think with conscientiousness.
DR. FARRINGTON DANIELS, JR. (Portland,
Oregon): Dr. Knox should be complimented for
another contribution in his studies of light
sensitivity.
I would like to ask one question, whether the
Texas group still believes the psoralens in any
form protect against the carcinogenic effect of
ultraviolet light in mice? Pathak (Pathak,
M. A., F. Daniels, C. E. Hopkins and T. B.
Fitzpatrick: Ultraviolet Carcinogenesis in Albino
and Pigmented Mice Receiving Furoeoumarins:
Psoralen and 8-methoxypsoralen. Nature 183:
728, 1959) has been unable to confirm the earlier
report by O'Neal and Griffin. (Cancer Res. 17:
911, 1957).
Next, I would like to mention the merits of
the benzophenone sunscreen (Uvinul) ointments
which Dr. Knox described at this meeting two
years ago. (Knox, J. M., J. Gum, E. G. Cockerell.
Benzophenones, Ultraviolet light absorbing
agents. J. Inv. Derm. 29: 435, 1957)
This has not been picked up by any commercial
enterprises. I find this hard to understand. This
sunscreen ointment is an excellent preparation,
particularly for patients with sensitivity in the
long wave ultraviolet. The benzophenones are
also incorporated into plastic sheets, which are
commercially available as transparent shades in
store windows to prevent fading of furniture
and paint. This plastic material can be placed
over windows to protect ultraviolet sensitive
patients without interfering with vision.
DR. IRA L. ScJJAMBERG (Elkins Park, Pa.):
When psoralens were injected into mice subjected
to ultraviolet light irradiation, photosensitivity
increased, when ingested it decreased, (1, 2).
What is the explanation for this? Is it simply a
matter of dosage?
1. A. CLARK, GRIFFIN, Ph.D. Methoxalen in
Ultraviolet Carcinogenesis in the Mouse.
J. Invest Derm., 32: 367, February 1959.
2. FREDERICK URBAcJ, M.D. Modification of
Ultraviolet Careinogenesis by Photoaetive
Agents. Preliminary Report. J. Invest Derm.,
32: 373, Feb. 1959.
DR. OTTO C. STEGMAIER (Davenport, Iowa):
I appreciate the opportunity to thank Dr. Knox
for ferreting out the benzophenones from the
plastic industry, and making them known to us
in Dermatology. They appear to be the best
pan-ultra violet sunscreen, filtering out all ultra
violet below 4000 A. Ultraviolet, prior to the
use of the benzophenones could not completely
be filtered out by sun screens. Since the longer
wave ultraviolet is responsible for darkening of
chloasma and causing many cases of poly-
morphic light eruptions, it is important that we
have a better ultraviolet protective screen.
I have repeated the protective experiment
comparing 10% Uvinul cream and PABA 15%
as an ultraviolet screen while the patients were
on 30 mgm of methoxsalen. Three patients were
exposed on different occasions to hot quartz
ultraviolet, long wave ultraviolet fluorescent
light and sunlight.
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The best protective action was exhibited by
TJvinul in 3 of 3 patients after exposure to sun-
light and long wave fluorescent light, and 2 out
of 3 patients after exposure to hot quartz ultra
violet.
Dn. JoHN M. KNOX (in closing): I wish to
thanh the discussers. To answer Dr. Lorinez
first, only the protected areas do not develop
tumors. Therefore, the area that you wish to
protect should have the benzophenone topical
application. The benzophenones and PABA are
excellent, and either one in a high concentration
should be effective. I would like to see the physi-
cians leave this meeting, go back to their com-
munities, and advocate the use of sunscreens for
the fair-skinned individuals who are susceptible
to skin cancers. Such individuals should apply
sunscreens whenever they play golf, whenever
they are at the beach, or what have you, in order
to decrease both earcinogenesis and premature
aging of the skin.
We have not done any chemical studies on
the ears of these mice.
In respect to Dr. Rothman's and Dr. Sulz-
berger's comments, I think most patients would
do just what we ask if we adequately emphasize
the need. I appreciate the comments of Dr.
Rothman and Dr. Sulzberger in this regard.
In consideration of possible protection from
psoralens, our studies to date in animals indicate
that for light-skinned individuals the psoralens
are possibly carcinogenic and we do not advocate
them except where definitely indicated in
selected cases of vitiligo.
I wish to thank Dr. Stegmaier for again con-
firming the applicability of some of our findings
to humans. Many people emphasize that knowl-
edge obtained from animal experiments does not
necessarily find applicability in humans.
